Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.98Enterprise Value over EBITDA
VS
Market
Sector
Industry
History
$ 1.54Close
$ 0.57 - $ 5.04 52-Week Range
Ticker Information
Ticker
IRWDCompany Name
IRONWOOD PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQIRONWOOD PHARMACEUTICALS INC - Enterprise Value over EBITDA Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IRWD - EV/EBITDA Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
|---|---|---|---|
| 6/30/2025 | $ 80.44M | $ 641.61M | 7.98 |
| 3/31/2025 | $ 60.23M | $ 609.38M | 10.12 |
| 12/31/2024 | $ 100.24M | $ 748.78M | 7.47 |
| 9/30/2024 | $ 106.8M | $ 1.27B | 11.91 |
| 6/30/2024 | $ 123.16M | $ 1.18B | 9.59 |
| 3/31/2024 | $ -977.81M | $ 1.64B | 0 |
| 12/31/2023 | $ -895.54M | $ 2.91B | 0 |
| 9/30/2023 | $ -888.66M | $ 2.12B | 0 |
| 6/30/2023 | $ -860.51M | $ 2.14B | 0 |
| 3/31/2023 | $ 269.95M | $ 1.32B | 4.88 |
Key Performance Insights, Last 5 Years
- IRONWOOD PHARMACEUTICALS INC's latest trailing twelve months (TTM) EV/EBITDA stands at 12.04.
- Over the past 5 years, IRONWOOD PHARMACEUTICALS INC's average EV/EBITDA has been 8.6.
- The median EV/EBITDA for IRONWOOD PHARMACEUTICALS INC during this period was 8.22
- IRONWOOD PHARMACEUTICALS INC reached its highest EV/EBITDA over the past 5 years at 12.04.
- The lowest EV/EBITDA recorded by IRONWOOD PHARMACEUTICALS INC in the same timeframe 4.88
IRONWOOD PHARMACEUTICALS INC's EV/EBITDA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/EBITDA Benchmarks
Similar metrics to EV/EBITDA:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) - [Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
Definition of Enterprise Value over EBITDA
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].EV / EBITDA
(=) EV/EBITDA EV/EBITDA for IRONWOOD PHARMACEUTICALS INC is calculated as follows: EV [ $ 1.75B ] / EBITDA [ $ 145.31M ]
(=) EV/EBITDA [ 12.04 ] IRWD - Enterprise Value over EBITDA, Last 5 years
4.88
Minimum
Mar 31, 2023
12.04
Maximum
Sep 30, 2020
8.6
Average
8.22
Median
EV/EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.48 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
| filtered constituents | 2.44K |
|---|---|
| min | 0.01 |
| max | 40.82 |
| average | 13.48 |
| median | 11.75 |
| std | 7.65 |